IMMULAB
Live / Registered — Registered (as of 10 Jan 2023)
What this means for you
Registered since 10 Jan 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79336602
- Registration number
- 6945376
- Mark type
- Design + words
- Filed
- 04 Oct 2021
- Published for opposition
- 25 Oct 2022
- Registered
- 10 Jan 2023
- Attorney of record
- Rebecca Liebowitz
Goods and services
- Class 001 — Chemicals: Chemical and biological reagents for non-medical purposes; chemical test kits comprised of chemical preparations for the detection of specific blood cells, determining the presence of antigens on blood cells, and the detection of relevant complement compounds and immunoglobulin subtypes for laboratory or research use; chemical preparations for scientific and/or industrial purposes; diagnostic and chemical reagents for testing for scientific and research purposes; chemical and biological reagents for non-medical purposes; chemical and biological reagents for anti-body screening, blood grouping, and for the typing and detection of specific blood cells, determining the presence of antigens on blood cells, and the detection of relevant complement compounds and immunoglobulin subtypes, all the aforesaid being for scientific and research purposes; chemical test kits for the detection of specific blood cells, determining the presence of antigens on blood cells, and the detection of relevant complement compounds and immunoglobulin subtypes for laboratory or research use; chemical preparations for anti-body screening, blood grouping, and the typing and detection of specific blood cells for scientific and research purposes
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances, namely, blood grouping serums and blood typing serums, namely, medical reagents and assays for testing blood to determine blood type; blood components for medical purposes, namely, platelets, plasma and red blood cells; pharmaceutical test kits in this class, being for diagnostic medical purposes, namely, diagnostic test kits comprised of medical diagnostic reagents and assays for clinical laboratory use in use in blood grouping and antibody screening; blood products for medical purposes, namely, blood plasma, reagent blood cells; reagents for medical use, namely, reagents for the typing and detection of specific blood cells, and the detection of relevant compliment components and immunoglobulin subtypes; clinical medical reagents for the typing and detection of specific blood cells, and the detection of relevant compliment components and immunoglobulin subtypes; pharmaceutical preparations, namely, reagent red blood cells used for quality control in immunohematology tests to detect antibodies or immunoglobulin subtypes; diagnostic reagents for medical or veterinary use; pharmaceutical preparations, namely, reagent red blood cells for medical use and medical testing used to detect antibodies or immunoglobulin subtypes; test kits comprised of medical diagnostic reagents and assays for testing of body fluids; chemical reagents for medical purposes; biological reagents for medical use
Owner
- Immulab Pty Ltd, AU
- Immulab Pty Ltd, AU
- Immulab Pty Ltd, AU
Prosecution history
- 15 Aug 2025 — NEW REPRESENTATIVE AT IB RECEIVED
- 17 May 2023 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 26 Apr 2023 — FINAL DISPOSITION NOTICE SENT TO IB
- 26 Apr 2023 — FINAL DISPOSITION PROCESSED
- 10 Apr 2023 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 10 Jan 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 10 Jan 2023 — REGISTERED-PRINCIPAL REGISTER
- 25 Oct 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 25 Oct 2022 — PUBLISHED FOR OPPOSITION
- 05 Oct 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 19 Sept 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 26 Aug 2022 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 25 Aug 2022 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 25 Aug 2022 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 23 Aug 2022 — REFUSAL PROCESSED BY IB